{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:00:50Z","timestamp":1793307650170,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/shk.0b013e3182429b38","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T17:51:11Z","timestamp":1322761871000},"page":"247-252","source":"Crossref","is-referenced-by-count":6,"title":["Biological and Technical Considerations Regarding the Removal of Bacteriotoxins in Sepsis With Emphasis on Toxic Shock Syndrome Toxin 1"],"prefix":"10.1097","volume":"37","author":[{"given":"Walter J.","family":"Brummelhuis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap A.","family":"Joles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jord","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Theo","family":"Verrips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Braam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"R1-3-20210213","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00003246-199506000-00008","article-title":"Long-term survival after intensive care unit admission with sepsis.","volume":"23","author":"Sasse","year":"1995","journal-title":"Crit Care Med"},{"issue":"7","key":"R2-3-20210213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"6","key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"457","DOI":"10.7326\/0003-4819-115-6-457","article-title":"The pathogenesis of sepsis.","volume":"115","author":"Bone","year":"1991","journal-title":"Ann Intern Med"},{"issue":"9328","key":"R4-3-20210213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","article-title":"Association between mitochondrial dysfunction and severity and outcome of septic shock.","volume":"360","author":"Brealey","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"R5-3-20210213","first-page":"2","article-title":"Alterations in nitric oxide production in various forms of circulatory shock.","volume":"3","author":"Szabo","year":"1995","journal-title":"New Horiz"},{"issue":"2","key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/CCM.0b013e318194d117","article-title":"Vasopressin and its copilot copeptin in sepsis and septic shock.","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"issue":"4","key":"R7-3-20210213","first-page":"222","article-title":"Elevated plasma levels of endothelin in patients with sepsis syndrome.","volume":"33","author":"Weitzberg","year":"1991","journal-title":"Circ Shock"},{"issue":"4","key":"R8-3-20210213","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/cc6988","article-title":"Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients.","volume":"12","author":"Wang","year":"2008","journal-title":"Crit Care"},{"issue":"17","key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1073\/pnas.97.17.9753","article-title":"Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock.","volume":"97","author":"Macarthur","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-3-20210213","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-065X.2008.00681.x","article-title":"The bacterial superantigen and superantigen-like proteins.","volume":"225","author":"Fraser","year":"2008","journal-title":"Immunol Rev"},{"issue":"5","key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","article-title":"Gram-positive toxic shock syndromes.","volume":"9","author":"Lappin","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/JCM.42.6.2875-2876.2004","article-title":"Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.","volume":"42","author":"Schlievert","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"6","key":"R15-3-20210213","first-page":"494","article-title":"Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study.","volume":"23","author":"Bengsch","year":"2005","journal-title":"Shock"},{"issue":"2","key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00024382-199602000-00011","article-title":"Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration.","volume":"5","author":"Bottoms","year":"1996","journal-title":"Shock"},{"issue":"5","key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/SHK.0b013e318188dec5","article-title":"Coupled plasma filtration adsorption in experimental peritonitis-induced septic shock.","volume":"31","author":"Sykora","year":"2009","journal-title":"Shock"},{"issue":"10","key":"R20-3-20210213","first-page":"559","article-title":"Sepsis: clearing the blood in sepsis. Nature reviews.","volume":"5","author":"Vincent","year":"2009","journal-title":"Nephrology"},{"issue":"30","key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.2174\/092986709789352321","article-title":"Staphylococcus aureus: the toxic presence of a pathogen extraordinaire.","volume":"16","author":"Larkin","year":"2009","journal-title":"Curr Med Chem"},{"issue":"4","key":"R23-3-20210213","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/146.4.456","article-title":"Recovery of staphylococcal enterotoxin F from the breast milk of a woman with toxic-shock syndrome.","volume":"146","author":"Vergeront","year":"1982","journal-title":"J Infect Dis"},{"issue":"2","key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.32.2.539-542.1994","article-title":"Rapid assay for detection of toxic shock syndrome toxin 1 from human sera.","volume":"32","author":"Miwa","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"5","key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijid.2003.12.005","article-title":"Detection of circulating superantigens in an intensive care unit population.","volume":"8","author":"Azuma","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"2","key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SHK.0b013e3181cdc556","article-title":"Llama heavy-chain antibody fragments efficiently remove toxic shock syndrome toxin 1 from plasma in vitro but not in experimental porcine septic shock.","volume":"34","author":"Brummelhuis","year":"2010","journal-title":"Shock"},{"issue":"3","key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000091851","article-title":"Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration-controlled septic swine.","volume":"24","author":"Miwa","year":"2006","journal-title":"Blood Purif"},{"issue":"1","key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2005.01.006","article-title":"Superantigen-induced multiple organ dysfunction in a toxin-concentration-controlled and sequential parameter-monitored swine sepsis model.","volume":"10","author":"Miwa","year":"2006","journal-title":"Int J Infect Dis"},{"issue":"4","key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/infdis\/164.4.711","article-title":"Effects of staphylococcal toxic shock syndrome toxin 1 on aortic endothelial cells.","volume":"164","author":"Lee","year":"1991","journal-title":"J Infect Dis"},{"issue":"49","key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1021\/bi801468w","article-title":"Novel toxic shock syndrome toxin-1 amino acids required for biological activity.","volume":"47","author":"Brosnahan","year":"2008","journal-title":"Biochemistry"},{"issue":"5","key":"R31-3-20210213","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1348-0421.1989.tb01986.x","article-title":"Bindings of toxic shock syndrome toxin-1 and staphylococcal enterotoxins A, B, and C to rabbit spleen cells.","volume":"33","author":"Fujikawa","year":"1989","journal-title":"Microbiol Immunol"},{"issue":"4","key":"R32-3-20210213","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/IAI.73.4.2164-2174.2005","article-title":"The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.","volume":"73","author":"Peterson","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1084\/jem.170.6.2011","article-title":"The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate TB cell interaction.","volume":"170","author":"Mourad","year":"1989","journal-title":"J Exp Med"},{"issue":"8","key":"R34-3-20210213","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.185.8.1447","article-title":"Transcytosis of staphylococcal superantigen toxins.","volume":"185","author":"Hamad","year":"1997","journal-title":"J Exp Med"},{"issue":"3","key":"R36-3-20210213","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/505428","article-title":"Toxic shock syndrome toxin-1 challenges the neuroprotective functions of the choroidal epithelium and induces neurotoxicity.","volume":"194","author":"Batisson","year":"2006","journal-title":"J Infect Dis"},{"issue":"4","key":"R38-3-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01709839","article-title":"High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig.","volume":"18","author":"Grootendorst","year":"1992","journal-title":"Intensive Care Med"},{"issue":"8","key":"R39-3-20210213","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/BF01709399","article-title":"Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock.","volume":"16","author":"Stein","year":"1990","journal-title":"Intensive Care Med"},{"issue":"6","key":"R41-3-20210213","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/cc370","article-title":"The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients.","volume":"3","author":"Toft","year":"1999","journal-title":"Crit Care"},{"issue":"3","key":"R42-3-20210213","first-page":"M322","article-title":"Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill.","volume":"37","author":"Bellomo","year":"1991","journal-title":"ASAIO Trans"},{"key":"R43-3-20210213","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000424620","article-title":"The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis.","volume":"116","author":"Sander","year":"1995","journal-title":"Contrib Nephrol"},{"issue":"6","key":"R44-3-20210213","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0310057X9302100603","article-title":"Cytokines in plasma and ultrafiltrate during continuous arteriovenous haemofiltration.","volume":"21","author":"Tonnesen","year":"1993","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"R46-3-20210213","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/CCM.0b013e3181962316","article-title":"Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial.","volume":"37","author":"Payen","year":"2009","journal-title":"Crit Care Med"},{"issue":"6","key":"R48-3-20210213","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s001340100963","article-title":"High-volume haemofiltration in human septic shock.","volume":"27","author":"Cole","year":"2001","journal-title":"Intensive Care Med"},{"issue":"11","key":"R50-3-20210213","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1097\/00003246-200011000-00001","article-title":"Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock.","volume":"28","author":"Honore","year":"2000","journal-title":"Critical Care Med"},{"key":"R52-3-20210213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000314855","article-title":"Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.","volume":"166","author":"Nakamura","year":"2010","journal-title":"Contrib Nephrol"},{"issue":"4","key":"R53-3-20210213","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0310057X0403200420","article-title":"Reductions in levels of bacterial superantigenscannabinoids by plasma exchange in a patient with severe toxic shock syndrome.","volume":"32","author":"Kohro","year":"2004","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"R54-3-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1537-2995.1993.33393174451.x","article-title":"Plasma exchange does not improve survival in a canine model of human septic shock.","volume":"33","author":"Natanson","year":"1993","journal-title":"Transfusion"},{"issue":"1","key":"R55-3-20210213","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jca.2920010108","article-title":"Review: deficiencies in the eutrophils system of newborn infants, and the use of leukocyte transfusions in the treatment of neonatal sepsis.","volume":"1","author":"Christensen","year":"1982","journal-title":"J Clin Apher"},{"issue":"3","key":"R56-3-20210213","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/clind\/15.3.424","article-title":"Plasma and whole blood exchange in meningococcal sepsis.","volume":"15","author":"van Deuren","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"1","key":"R57-3-20210213","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/00365549009023123","article-title":"Continuous removal of leucocytes during early gram-negative septicemia reduces plasma levels of endotoxin and improves cardiac performance.","volume":"22","author":"Rokke","year":"1990","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"R58-3-20210213","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jss.2010.06.021","article-title":"Filtration leukocytapheresis therapy ameliorates lipopolysaccharide-induced systemic inflammation in a rat model.","volume":"171","author":"Hagiwara","year":"2011","journal-title":"J Surg Res"},{"issue":"1","key":"R59-3-20210213","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1201-9712(03)90038-5","article-title":"Preparation of a superantigen-adsorbing device and its superantigen removal efficacies in vitro and in vivo.","volume":"7","author":"Miwa","year":"2003","journal-title":"Int J Infect Dis"},{"issue":"1","key":"R60-3-20210213","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/156.1.122","article-title":"Binding of toxic-shock-syndrome toxin-1 to human peripheral blood mononuclear cells.","volume":"156","author":"Poindexter","year":"1987","journal-title":"J Infect Dis"},{"issue":"4","key":"R61-3-20210213","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/jmbi.1996.0421","article-title":"The refined crystal structure of toxic shock syndrome toxin-1 at 2.07. A resolution.","volume":"260","author":"Papageorgiou","year":"1996","journal-title":"J Mol Biol"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SHK.0b013e3182429b38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:25:06Z","timestamp":1620973506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-201203000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3182429b38","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}